Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/1996
10/09/1996EP0736097A1 Plant pathogen resistance genes and uses thereof
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736092A1 Vector systems for the generation of adeno-associated virus particles
10/09/1996EP0736088A1 Monoclonal antibodies to hepatitis e virus and methods for using same
10/09/1996EP0736087A1 Monoclonal antibodies against hev orf-2 and methods for using same
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0736002A1 Compound capable of introducing at least one molecule into a cell
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0724648A4 Methods for screening antiestrogen compounds
10/09/1996CN1133065A Lettuce infectious yellows virus genes
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1132792A Method of producing taxane-type diterpene
10/09/1996CN1132791A Recombinant DNA viral vector for transfecting animal cells
10/08/1996US5563215 Method of attaching dialdehyde starch to a surface and products produced by that method
10/08/1996US5563061 Method for reproducing conifers by somatic embryogenesis using a maltose enriched maintenance medium
10/08/1996US5563059 Use of human inhibin and human activin to increase the number of mature primate oocytes
10/08/1996US5563055 Method of Agrobacterium-mediated transformation of cultured soybean cells
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996CA2110266C Enhancement of expression by gene targeting in endogenous retrovirus-like sequences
10/07/1996CA2170073A1 Non-a, non-b, non-c, non-d, non-e hepatitis reagents and methods for their use
10/03/1996WO1996030765A1 Assaying protein fragments in body fluids
10/03/1996WO1996030540A2 Substrates for beta-lactamase and uses thereof
10/03/1996WO1996030535A1 Gene transfer into the kidney
10/03/1996WO1996030533A1 Pseudotyped retroviral particles
10/03/1996WO1996030532A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996WO1996030531A1 Gene expression in mammalian cells
10/03/1996WO1996030518A1 Plant pathogen resistance genes and uses thereof
10/03/1996WO1996030516A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996WO1996030515A1 Methods and associated reagents for detecting modulators of cytokine action
10/03/1996WO1996030514A1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies
10/03/1996WO1996030505A1 Methods for screening compounds for estrogenic activity
10/03/1996WO1996030500A1 Culture medium for insect cells
10/03/1996WO1996030499A1 Cell line and process for multiplying rabies viruses and their quantitative detection
10/03/1996WO1996030498A1 Production of antibodies using cre-mediated site-specific recombination
10/03/1996WO1996030497A1 Compartmentalized tissue culture bag
10/03/1996WO1996030496A1 Human embryo co-culture system and uses thereof
10/03/1996WO1996030493A2 Promoters derived from acc oxidase genes
10/03/1996WO1996030492A1 Filter device
10/03/1996WO1996030408A1 Antibody to the syncytiotrophoblast antigen r80k and use thereof
10/03/1996WO1996030406A1 Human g-protein coupled receptors
10/03/1996WO1996030403A1 Methods of treating disorders of the eye
10/03/1996WO1996030400A1 THE gC1q RECEPTOR, HIV-1 gp120 REGION BINDING THERETO, AND RELATED PEPTIDES AND TARGETING ANTIBODIES
10/03/1996WO1996030101A1 Centrifugal fermentation process
10/03/1996WO1996030050A1 Gene therapy by secretory gland expression
10/03/1996WO1996030038A1 Peptide growth factor having epidermal inducing activity
10/03/1996WO1996030031A1 Isolated stromal cells and methods of using the same
10/03/1996WO1996030030A1 Dendritic-like cell/tumor cell hybrids and hybridomas for inducing an anti-tumor response
10/03/1996WO1996029858A1 Transgenic plants with altered senescence characteristics
10/03/1996CA2217009A1 T-cell receptors and their use in therapeutic and diagnostic methods
10/03/1996CA2216467A1 Centrifugal fermentation process
10/03/1996CA2216445A1 Gene therapy for transplantation and inflammatory or thrombotic conditions
10/03/1996CA2216174A1 Gene expression in mammalian cells
10/03/1996CA2216149A1 Gene therapy by secretory gland expression
10/03/1996CA2215496A1 Plant pathogen resistance genes and uses thereof
10/03/1996CA2215330A1 Methods of treating disorders of the eye
10/03/1996CA2215143A1 Isolated stromal cells and methods of using the same
10/03/1996CA2215071A1 Filter device
10/03/1996CA2214499A1 Gene transfer into the kidney
10/03/1996CA2212413A1 Dna constructs and plants incorporating them
10/03/1996CA2191189A1 Methods and associated reagents for detecting modulators of cytokine action
10/02/1996EP0735135A2 Cell sheets and transport system for cell sheets
10/02/1996EP0734446A1 Controlled expression of transgenic constructs in plant plastids
10/02/1996EP0734445A1 Chimeric geens and methods for increasing the lysine content of the seeds of corn, soybean and rapeseed plants
10/02/1996EP0734443A1 Genes encoding branched-chain alpha-ketoacid dehydrogenase complex from streptomyces avermitilis
10/02/1996EP0734442A1 Diagnosis of metastatic cancer by the mts-1 gene
10/02/1996EP0734440A1 Tumor cell fusions and methods for use of such tumor cell fusions
10/02/1996EP0734439A1 p53-BINDING POLYPEPTIDES AND POLYNUCLEOTIDES ENCODING SAME
10/02/1996EP0653943A4 Targeting somatic gene therapy to joints.
10/02/1996EP0640124B1 Variable volume reactor-type device and process for the culture of cellular material
10/02/1996EP0487617B1 Synthetic peptides that enhance cell binding
10/02/1996EP0485578B1 Neurotropic growth factors comprising a homeobox peptide
10/02/1996DE19513177A1 Cell layer prepn. and transport system for use in skin transplants
10/02/1996DE19512057A1 Zellinie und Verfahren zur Vermehrung von Tollwutviren und deren quantitativen Nachweis Cell line and method for propagating rabies viruses and their quantitative detection
10/02/1996CN1132516A Monoclonal IgA antibody against respiratory syncytial virus
10/02/1996CN1132514A Protective antigens against parasites
10/01/1996US5561236 Plant cell into which a gene has been introduced, the expression of which inhibits the antibiotic and herbicidal effects of bialaphos and phosphinothricin
10/01/1996US5561053 Dna molecule containing transcriptional regulatory regions, for genetic engineering
10/01/1996CA1338620C Regulation of gene expression
09/1996
09/26/1996WO1996029605A2 Compounds and methods for the dectection of t. cruzi infection
09/26/1996WO1996029604A1 Method for diagnosing a patient for chlamydia
09/26/1996WO1996029422A1 Nucleic acid carrier
09/26/1996WO1996029421A1 Vectors for gene delivery
09/26/1996WO1996029417A1 Il-13 receptor specific chimeric proteins and uses thereof
09/26/1996WO1996029411A1 Protein production and delivery
09/26/1996WO1996029409A2 Rage tumor rejection antigens
09/26/1996WO1996029408A1 Il-17 receptor
09/26/1996WO1996029404A1 HUMAN METABOTROPIC GLUTAMATE RECEPTOR SUBTYPE mGluR6
09/26/1996WO1996029401A1 Human b-cell translocation genes-2 and 3
09/26/1996WO1996029395A1 Cell culture method
09/26/1996WO1996029394A1 Method for treating tumors
09/26/1996WO1996029349A1 Monoclonal antibody specifically recognizing adeno-associated virus cap protein
09/26/1996WO1996029341A1 Human stat4
09/26/1996WO1996029338A1 Identification of gene mutations associated with congenital lipoid adrenal hyperplasia
09/26/1996WO1996023071A3 MONOCLONAL ANTIBODIES SPECIFIC FOR DIFFERENT EPITOPES OF HUMAN gp39 AND METHODS FOR THEIR USE IN DIAGNOSIS AND THERAPY
09/26/1996WO1996023065A3 Inhibition of neovascularization using vegf-specific oligonucleotides
09/26/1996WO1996017924A3 Novel hedgehog-derived polypeptides
09/26/1996DE19511126A1 Substrate cell layers, e.g. for transplantation
09/26/1996CA2215730A1 Human metabotropic glutamate receptor subtype mglur6